SBI Securities’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80
Closed -$246 4100
2025
Q4
$246 Hold
80
﹤0.01% 3146
2025
Q3
$522 Sell
80
-5
-6% -$37 ﹤0.01% 2944
2025
Q2
$762 Hold
85
﹤0.01% 2793
2025
Q1
$540 Hold
85
﹤0.01% 2841
2024
Q4
$881 Buy
+85
New +$935 ﹤0.01% 2672

Other funds holding LYRA

SBI Securities's LYRA Position: Q1 2026 in Review

SBI Securities sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 80 shares — an estimated $246 sold.

SBI Securities first reported a position in LYRA in Q4 2024 and held it in 5 quarters. The position peaked at $881 in Q4 2024. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

  • SBI Securities reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • SBI Securities sold 80 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $246.
  • SBI Securities first reported a position in LYRA THERAPEUTICS INC in Q4 2024 and held it in 5 quarters.
  • SBI Securities's LYRA THERAPEUTICS INC position peaked at $881 in Q4 2024.
  • 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.